Medical University of South Carolina partners with Shoreline Behavioral Health Services to introduce clinical trials.
Clinical Trial 1: Clinical Trial Network’s (CTN) Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
Purpose of the Research Study
The purpose of this research study is to test approaches to improve outcomes for patients who want to discontinue their medication for opioid use disorder after a period of remaining stable on medication.
For more information click here for more detailed information regarding the study via ClinicalTrials.gov.
or contact the Study Coordinator at 843-614-9510
Clinical Trial 2: UH3 – Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
Background
Researchers at Shoreline Behavioral Health Services are conducting a research study to test a new combination of medicines for outpatient treatment of opioid withdrawal.
Findings from this clinical research study will determine whether new approaches to treating withdrawal will improve our ability to use extended-release naltrexone (Vivitrol) as relapse prevention medication.
Potential participants will be screened and, if eligible, will be randomized to receive either Lofexidine + Pregabalin OR Lofexidine + Placebo. There will be daily check-ins during the 8-day outpatient opioid detoxification to determine withdrawal symptoms.
For more information click here for more detailed information regarding the study via ClinicalTrials.gov.
or contact the Study Coordinator at 843-614-9510
